Dr. Michael Raff, M.D.

Claim this profile

MultiCare Institute for Research & Innovation

Studies Fragile X Syndrome
Studies Syndrome
1 reported clinical trial
3 drugs studied

Area of expertise

1Fragile X Syndrome
Michael Raff, M.D. has run 1 trial for Fragile X Syndrome. Some of their research focus areas include:
FMR1
FMR1 positive
2Syndrome
Michael Raff, M.D. has run 1 trial for Syndrome. Some of their research focus areas include:
FMR1
FMR1 positive

Affiliated Hospitals

Image of trial facility.
MultiCare Institute For Research & Innovation

Clinical Trials Michael Raff, M.D. is currently running

Image of trial facility.

Cannabidiol Gel

for Fragile X Syndrome

This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). Eligible participants will participate in up to an 18-week treatment period, where all participants will receive placebo or active study drug. Patients ages 3 to \< 30 years will be eligible to participate.
Recruiting1 award Phase 311 criteria

More about Michael Raff, M.D.

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Raff, M.D. has experience with
  • Placebo
  • ZYN002 - CBD Transdermal Gel
  • ZYN002 - Transdermal Gel
Breakdown of trials Michael Raff, M.D. has run
Fragile X Syndrome
Syndrome

Other Doctors you might be interested in

Bhuvana SunilMultiCare Institute for Research & Innovation
Jon Ween, MDMultiCare Institute for Research & Innovation
Abhishek MarballiMultiCare Institute for Research & Innovation

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Raff, M.D. specialize in?
Michael Raff, M.D. focuses on Fragile X Syndrome and Syndrome. In particular, much of their work with Fragile X Syndrome has involved FMR1 patients, or patients who are FMR1 positive.
Is Michael Raff, M.D. currently recruiting for clinical trials?
Yes, Michael Raff, M.D. is currently recruiting for 1 clinical trial in Tacoma Washington. If you're interested in participating, you should apply.
Are there any treatments that Michael Raff, M.D. has studied deeply?
Yes, Michael Raff, M.D. has studied treatments such as Placebo, ZYN002 - CBD transdermal gel, ZYN002 - transdermal gel.
What is the best way to schedule an appointment with Michael Raff, M.D.?
Apply for one of the trials that Michael Raff, M.D. is conducting.
What is the office address of Michael Raff, M.D.?
The office of Michael Raff, M.D. is located at: MultiCare Institute for Research & Innovation, Tacoma, Washington 98402 United States. This is the address for their practice at the MultiCare Institute for Research & Innovation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top